Discover trends, market shifts, and competitive outlooks for the neurogenetic testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Neurogenetic Testing Market Size from 2025 to 2034?

The market size of neurogenetic testing has experienced a significant upturn in recent times. The forecast sees a surge from $0.61 billion in 2024 to $0.7 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%. Factors that contributed to this historical growth include the higher incidence rates of neurological diseases, heightened research activity in the life sciences sector, an increased prevalence of Parkinson’s disease, a rising number of cancer cases, and growing consciousness amongst medical professionals.

The market size for neurogenetic testing is anticipated to experience swift expansion over the next few years. The market is projected to reach $1.16 billion in 2029, boasting a compound annual growth rate (CAGR) of 13.5%. This growth during the forecast period can be credited to the surge in personalized medicine applications, the rise in chronic illnesses, a growing count of hospitals, an upswing in diagnostic labs, and an increasing demand for early disease diagnosis. Key trends forecast for this period include the advancements in technology, a higher frequency of non-invasive testing methods, the development of new products, strategic partnerships, and the emergence of new biomarkers pertinent to neurological disorders.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16131&type=smp

What Are the Core Growth Drivers Propelling the Neurogenetic Testing Market Forward?

The escalating numbers of neurological conditions are anticipated to stimulate the development of the neurogenetic testing sector. Neurological conditions pertain to any disease impacting the nervous system, including the brain, spinal cord, and nerves. The emergence of these conditions can be attributed to genetic vulnerability, infections, trauma, toxins, autoimmune reactions, and degeneration. Neurogenetic assessments significantly boost the diagnosis, treatment, and management of these disorders by providing personalized insights on genetic risk elements, informing treatment options, and enabling individuals and families to make knowledgeable healthcare decisions, consequently enhancing patient care and outcomes. For example, in April 2022, based on data from the European Brain Council, a non-profit organization from Belgium, over 600 neurological and nearly 300 psychiatric conditions afflict millions worldwide, including 65 million who suffer from epilepsy. In Europe, dementia affects 10.5 million people, with forecasts predicting a surge to 18.7 million by 2050. As a result, the escalating numbers of neurological conditions are predicted to impel the development of the neurogenetic testing sector.

Neurogenetic Testing Market Driver: A Surge in Cancer Cases Promotes Growth in Neurogenetic Testing Market

Which Key Market Segments Comprise the Neurogenetic Testing Market and Drive Its Revenue Growth?

The neurogenetic testing market covered in this report is segmented –

1) By Type: Microarray Analysis, Whole-Exome Sequencing (WES), Multiplex Ligation Dependent Probe Amplification (MLPA), Polymerase Chain Reaction (PCR) Tests, Other Types

2) By Disease: Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Fragile X Syndrome, Other Diseases

3) By End-Users: Hospitals, Specialty Clinics, Research Institutes, Diagnostics Laboratories

Subsegments:

1) By Microarray Analysis: Comparative Genomic Hybridization (CGH) Microarray, Single Nucleotide Polymorphism (SNP) Microarray, Gene Expression Microarray

2) By Whole-Exome Sequencing (WES): Targeted Exome Sequencing, Clinical Exome Sequencing, Research-Grade Exome Sequencing

3) By Multiplex Ligation Dependent Probe Amplification (MLPA): MLPA For Copy Number Variation, MLPA For Methylation Analysis, MLPA For Specific Disease Detection

4) By Polymerase Chain Reaction (PCR) Tests: Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR (dPCR)

5) By Other Types: Next-Generation Sequencing (NGS), Southern Blotting, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16131&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Neurogenetic Testing Market?

North America was the largest region in the neurogenetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Neurogenetic Testing Industry Evolution?

Big players in the neurogenetic testing market are focused on delivering innovative products, such as whole-genome sequencing in an attempt to improve the precision and range of genetic analysis, thereby providing more thorough and personalized tests for neurological conditions. Whole-genome sequencing (WGS) constitutes a detailed method of genetic testing that discerns the full DNA sequence of a person’s entire genome. For instance, in March 2024, Nucleus Genomics, a company based in the USA that specializes in genetic analysis, unveiled a novel product for DNA analysis. This platform equips people with a comprehensive understanding of their genetic predispositions which in turn aids them in forming knowledgeable decisions regarding their health and overall well-being. Armed with advanced technology and proficient genetic counseling services, Nucleus Genomics is poised to redefine the genetic testing landscape, making whole-genome sequencing directly accessible to individuals and bringing about a revolution in genomic medicine.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

How Is the Neurogenetic Testing Market Conceptually Defined?

Neurogenetic testing is a type of genetic testing that focuses on identifying genetic variations associated with neurological disorders or conditions affecting the nervous system. It is used for diagnosing, predicting, and managing neurological disorders, as well as facilitating research and the development of personalized treatment approaches in the field of neurology and genetics.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16131

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model